ArticleEndocrine2019

Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density.

Joanna Rymuza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.